TG Therapeutics Inc (MIL:1TGTX)
€ 33.5 (0%) Market Cap: 7.38 Bil Enterprise Value: 7.59 Bil PE Ratio: 19.18 PB Ratio: 14.40 GF Score: 57/100

TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 09:30 PM GMT
Release Date Price: €25.63


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TGTX.OQ - TG Therapeutics Inc
TG Therapeutics Inc at JPMorgan Healthcare Conference
Jan 13, 2026 / 09:30PM GMT

=====================
Conference Call Participants
=====================
* Lut Ming Cheng
* Michael Weiss

=====================
Presentation
--------------------------------------------------------------------------------
Lut Ming Cheng, [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm.

On stage, we have Mike Weiss, who is the CEO of TG Therapeutics. I'll now pass the mic to their CEO for a short presentation, followed by a live audience Q&A. Mike, the stage is yours.

--------------------------------------------------------------------------------
Michael Weiss, [2]
--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot